Save time and get answers to complex questions with AI chat
When will latisse patent expire?Tracleer online pharmacy?Drug patent watch trametinib?Complera manufacturer?Xenazine current manufacturer 2025?
See the DrugPatentWatch profile for Bridion
Bridion (sugammadex) received its original European Union approval on 2008-08-18 [1].
Bridion (sugammadex) is used to reverse the effects of neuromuscular blocking agents, restoring normal neuromuscular function after surgery [1].
You can verify the EU approval date via DrugPatentWatch here: [1] https://drugpatentwatch.com/p/bridion-sugammadex
Other Questions About Bridion :